Table 5.
LOH Profile in Paired Primary and In-Transit Tumors
| Patient | Tumor | Microsatellite marker | |||||||
|---|---|---|---|---|---|---|---|---|---|
| D1S214 | D1S228 | D3S1293 | D6S264 | D9S157 | D10S212 | D11S200 | D9S304 | ||
| 7 | P | R | R | H | H | R | R | L | R | 
| I1 | R | R | H | H | R | R | L | R | |
| I2 | R | R | H | H | R | R | L | L | |
| I3 | R | R | H | H | R | R | L | L | |
| I4 | R | R | H | H | R | R | L | L | |
| 8 | P | R | R | R | R | R | R | R | H | 
| I1 | R | R | R | R | R | R | R | H | |
| I2 | R | R | R | R | R | R | R | H | |
| 11 | P | H | H | R | R | L | R | R | R | 
| I1 | H | H | R | R | L | R | R | R | |
| I2 | H | H | R | R | L | R | R | R | |
| 13 | P | H | R | R | R | L | H | H | H | 
| I1 | H | R | R | R | L | H | H | H | |
| I2 | H | R | R | R | L | H | H | H | |
| 14 | P | H | R | R | R | H | H | R | R | 
| I1 | H | R | R | R | H | H | R | R | |
| I2 | H | R | R | R | H | H | R | R | |
| I3 | H | R | R | R | H | H | R | R | |
| 15 | P | L | L | R | H | H | R | R | H | 
| I1 | L | L | R | H | H | L | R | H | |
| I2 | L | L | R | H | H | L | R | H | |
| I3 | L | L | R | H | H | L | R | H | |
| I4 | L | L | R | H | H | L | R | H | |
| 16 | P | R | R | R | R | H | R | R | R | 
| I1 | R | R | R | R | H | L | R | R | |
| I2 | R | R | R | R | H | L | R | R | |
| I3 | R | R | R | R | H | L | R | R | |
| I4 | R | R | R | R | H | L | R | R | |
| I5 | R | R | R | R | H | L | R | R | |
| 18 | P | R | R | H | R | H | R | R | H | 
| I1 | R | R | H | R | H | R | R | H | |
| I2 | R | R | H | R | H | L | R | H | |
| 20 | P | R | R | R | R | H | H | R | R | 
| I1 | R | R | R | R | H | H | R | R | |
| I2 | R | R | R | L | H | H | L | R | |
| I3 | R | R | R | R | H | H | R | R | |
| 22 | P | R | R | H | R | R | L | R | R | 
| I1 | R | R | H | R | R | L | R | R | |
| I2 | R | R | H | R | R | L | R | R | |
P, primary; I(n), in-transit; R, retained; L, LOH.